Changes of NLF in Serum of Long COVID Patients

The study investigates the blood NFL levels in Long-COVID patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Clinical Syndrome

Age range

18 year–100 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Laura de Boni

Bonn, 53105, Germany

About this study

The study investigates the blood NFL levels in Long-COVID patients.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Long-COVID Syndrom

Treatment and study plan

Bloot testing

Diagnostic Test

NFL measruments in serum

Primary outcomes

Levels of NFL over a 1 year course of the Long-COVID Syndrom

Time frame: 1 year

see above

Sponsors and collaborators

Lead sponsor

University Hospital, Bonn

Other

Registry information

Important dates

Study start: 2020
Primary completion: 2021
Study completion: 2021
First posted: Sep 29, 2021
Registry last updated: Apr 28, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed